Complement C3 and incident hospitalization due to chronic kidney disease: a population-based cohort study-Reference-Cited by-同舟云学术

Complement C3 and incident hospitalization due to chronic kidney disease: a population-based cohort study

Published:2019-02-21 Issue:1 Volume:20 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Bao Xue^ORCID,Borné Yan,Muhammad Iram Faqir,Schulz Christina-Alexandra,Persson Margaretha,Orho-Melander Marju,Niu Kaijun,Christensson Anders,Engström Gunnar

Funder

the Medical Research Council of Sweden

the Swedish Heart–Lung Foundation

the China Scholarship Council

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s12882-019-1248-7.pdf

Reference38 articles.

1. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010;375:1296–309.

2. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260–72.

3. Herzog CA, Asinger RW, Berger AK, Charytan DM, Diez J, Hart RG, et al. Cardiovascular disease in chronic kidney disease. A clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2011;80:572–86.

4. Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ. 2010;341:c4986.

5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MASP‐2 deficiency does not prevent the progression of diabetic kidney disease in a mouse model of type 1 diabetes;Scandinavian Journal of Immunology;2023-12-25

2. Red cell distribution width and its polygenic score in relation to mortality and cardiometabolic outcomes;Frontiers in Cardiovascular Medicine;2023-11-20

3. Elevated circulating follistatin associates with increased risk of mortality and cardiometabolic disorders;Nutrition, Metabolism and Cardiovascular Diseases;2023-09

4. Complement C3 mediates podocyte injury through TLR4/NFΚB-P65 signaling during ischemia–reperfusion acute kidney injury and post-injury fibrosis;European Journal of Medical Research;2023-03-27

5. Can systemic immune inflammation index at admission predict in-hospital mortality in chronic kidney disease patients with SARS-CoV-2 infection?;Nefrología (English Edition);2022-09